Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Jesse Schold to Aged

This is a "connection" page, showing publications Jesse Schold has written about Aged.

 
Connection Strength
  
 
 
2.025
  
  1. Jackson WE, Lopez R, Forman LM, Arrigain S, Schold JD. Marked variation in disease acuity and outcomes on the liver transplant waiting list by sociodemographic characteristics. Liver Transpl. 2025 May 01; 31(5):584-595.
    View in: PubMed
    Score: 0.061
  2. Lopez R, Mohan S, Husain SA, Yu M, Arrigain S, Brosi D, Hoffman JRH, McCurry KR, Kaplan B, Pomfret EA, Schold JD. Crossing national borders for transplantation: A focused evaluation of deceased donor lung exports from the United States. Am J Transplant. 2025 Feb; 25(2):424-434.
    View in: PubMed
    Score: 0.060
  3. Forman LM, Jackson WE, Arrigain S, Lopez R, Schold JD. Socioeconomic deprivation is associated with worse patient and graft survival following adult liver transplantation. Liver Transpl. 2025 Feb 01; 31(2):211-220.
    View in: PubMed
    Score: 0.059
  4. Lopez R, Mohan S, Schold JD. Population Characteristics and Organ Procurement Organization Performance Metrics. JAMA Netw Open. 2023 10 02; 6(10):e2336749.
    View in: PubMed
    Score: 0.057
  5. Man S, Bruckman D, Tang AS, Uchino K, Schold JD. The Association of Socioeconomic Status and Discharge Destination with 30-Day Readmission after Ischemic Stroke. J Stroke Cerebrovasc Dis. 2021 Dec; 30(12):106146.
    View in: PubMed
    Score: 0.049
  6. Mohan S, King KL, Husain SA, Schold JD. COVID-19-Associated Mortality among Kidney Transplant Recipients and Candidates in the United States. Clin J Am Soc Nephrol. 2021 11; 16(11):1695-1703.
    View in: PubMed
    Score: 0.049
  7. Tsuang WM, Arrigain S, Lopez R, Snair M, Budev M, Schold JD. Patient Travel Distance and Post Lung Transplant Survival in the United States: A Cohort Study. Transplantation. 2020 11; 104(11):2365-2372.
    View in: PubMed
    Score: 0.046
  8. Crawford S, Schold J. Association Between Geographic Measures of Socioeconomic Status and Deprivation and Major Surgical Outcomes. Med Care. 2019 12; 57(12):949-959.
    View in: PubMed
    Score: 0.043
  9. Schold JD, Arrigain S, Flechner SM, Augustine JJ, Sedor JR, Wee A, Goldfarb DA, Poggio ED. Dramatic secular changes in prognosis for kidney transplant candidates in the United States. Am J Transplant. 2019 02; 19(2):414-424.
    View in: PubMed
    Score: 0.040
  10. Augustine JJ, Arrigain S, Balabhadrapatruni K, Desai N, Schold JD. Significantly Lower Rates of Kidney Transplantation among Candidates Listed with the Veterans Administration: A National and Local Comparison. J Am Soc Nephrol. 2018 10; 29(10):2574-2582.
    View in: PubMed
    Score: 0.039
  11. Tsuang WM, Lin S, Valapour M, Udeh BL, Budev M, Schold JD. The Association Between Lung Recipient Travel Distance and Posttransplant Survival. Prog Transplant. 2018 09; 28(3):231-235.
    View in: PubMed
    Score: 0.039
  12. Schold JD, Flechner SM, Poggio ED, Augustine JJ, Goldfarb DA, Sedor JR, Buccini LD. Residential Area Life Expectancy: Association With Outcomes and Processes of Care for Patients With ESRD in the United States. Am J Kidney Dis. 2018 07; 72(1):19-29.
    View in: PubMed
    Score: 0.038
  13. Hsich EM, Rogers JG, McNamara DM, Taylor DO, Starling RC, Blackstone EH, Schold JD. Does Survival on the Heart Transplant Waiting List Depend on the Underlying Heart Disease? JACC Heart Fail. 2016 09; 4(9):689-97.
    View in: PubMed
    Score: 0.034
  14. Navaneethan SD, Mandayam S, Arrigain S, Rahman M, Winkelmayer WC, Schold JD. Obstructive and Restrictive Lung Function Measures and CKD: National Health and Nutrition Examination Survey (NHANES) 2007-2012. Am J Kidney Dis. 2016 09; 68(3):414-21.
    View in: PubMed
    Score: 0.034
  15. Schold JD, Buccini LD, Poggio ED, Flechner SM, Goldfarb DA. Association of Candidate Removals From the Kidney Transplant Waiting List and Center Performance Oversight. Am J Transplant. 2016 Apr; 16(4):1276-84.
    View in: PubMed
    Score: 0.033
  16. Schold JD, Buccini LD, Rodrigue JR, Mandelbrot D, Goldfarb DA, Flechner SM, Kayler LK, Poggio ED. Critical Factors Associated With Missing Follow-Up Data for Living Kidney Donors in the United States. Am J Transplant. 2015 Sep; 15(9):2394-403.
    View in: PubMed
    Score: 0.032
  17. Schold JD, Buccini LD, Reese PP, Poggio ED, Goldfarb DA. Effect of dialysis initiation for preemptively listed candidates in the revised kidney allocation policy. Am J Transplant. 2014 Dec; 14(12):2855-60.
    View in: PubMed
    Score: 0.030
  18. Sakhuja A, Stephany B, Deitzer D, Kumar G, Schold JD. Trends of pulmonary embolism before and after kidney transplantation in black versus white patients. Transplant Proc. 2014 Jun; 46(5):1353-61.
    View in: PubMed
    Score: 0.030
  19. Heaphy EL, Poggio ED, Flechner SM, Goldfarb DA, Askar M, Fatica R, Srinivas TR, Schold JD. Risk factors for retransplant kidney recipients: relisting and outcomes from patients' primary transplant. Am J Transplant. 2014 Jun; 14(6):1356-67.
    View in: PubMed
    Score: 0.029
  20. Shoskes DA, Kerr H, Askar M, Goldfarb DA, Schold J. Low testosterone at time of transplantation is independently associated with poor patient and graft survival in male renal transplant recipients. J Urol. 2014 Oct; 192(4):1168-71.
    View in: PubMed
    Score: 0.029
  21. Schold JD, Goldfarb DA, Buccini LD, Rodrigue JR, Mandelbrot DA, Heaphy EL, Fatica RA, Poggio ED. Comorbidity burden and perioperative complications for living kidney donors in the United States. Clin J Am Soc Nephrol. 2013 Oct; 8(10):1773-82.
    View in: PubMed
    Score: 0.028
  22. Schold JD, Heaphy EL, Buccini LD, Poggio ED, Srinivas TR, Goldfarb DA, Flechner SM, Rodrigue JR, Thornton JD, Sehgal AR. Prominent impact of community risk factors on kidney transplant candidate processes and outcomes. Am J Transplant. 2013 Sep; 13(9):2374-83.
    View in: PubMed
    Score: 0.028
  23. Heaphy ELG, Goldfarb DA, Poggio ED, Buccini LD, Flechner SM, Schold JD. The impact of deceased donor kidney risk significantly varies by recipient characteristics. Am J Transplant. 2013 Apr; 13(4):1001-1011.
    View in: PubMed
    Score: 0.027
  24. Schold JD, Buccini LD, Srinivas TR, Srinivas RT, Poggio ED, Flechner SM, Soria C, Segev DL, Fung J, Goldfarb DA. The association of center performance evaluations and kidney transplant volume in the United States. Am J Transplant. 2013 Jan; 13(1):67-75.
    View in: PubMed
    Score: 0.027
  25. Navaneethan SD, Kirwan JP, Arrigain S, Schreiber MJ, Sarnak MJ, Schold JD. Obesity, anthropometric measures and chronic kidney disease complications. Am J Nephrol. 2012; 36(3):219-27.
    View in: PubMed
    Score: 0.026
  26. Fissell RB, Srinivas T, Fatica R, Nally J, Navaneethan S, Poggio E, Goldfarb D, Schold J. Preemptive renal transplant candidate survival, access to care, and renal function at listing. Nephrol Dial Transplant. 2012 Aug; 27(8):3321-9.
    View in: PubMed
    Score: 0.025
  27. Schold JD, Buccini LD, Goldfarb DA, Flechner SM, Hsich E, Mason D, Fung J, Stephany BR, Krishnamurthi V, Srinivas TR. Patient participation in research among solid organ transplant recipients in the United States. Transplantation. 2011 Jun 27; 91(12):1424-35.
    View in: PubMed
    Score: 0.024
  28. Schold JD, Gregg JA, Harman JS, Hall AG, Patton PR, Meier-Kriesche HU. Barriers to evaluation and wait listing for kidney transplantation. Clin J Am Soc Nephrol. 2011 Jul; 6(7):1760-7.
    View in: PubMed
    Score: 0.024
  29. Kayler LK, Sokolich J, Magliocca J, Schold JD. Import kidney transplants from nonmandatory share deceased donors: characteristics, distribution and outcomes. Am J Transplant. 2011 Jan; 11(1):77-85.
    View in: PubMed
    Score: 0.023
  30. Srinivas TR, Flechner SM, Poggio ED, Askar M, Goldfarb DA, Navaneethan SD, Schold JD. Glomerular filtration rate slopes have significantly improved among renal transplants in the United States. Transplantation. 2010 Dec 27; 90(12):1499-505.
    View in: PubMed
    Score: 0.023
  31. Schold JD, Navaneethan SD, Jolly SE, Poggio ED, Arrigain S, Saupe W, Jain A, Sharp JW, Simon JF, Schreiber MJ, Nally JV. Implications of the CKD-EPI GFR estimation equation in clinical practice. Clin J Am Soc Nephrol. 2011 Mar; 6(3):497-504.
    View in: PubMed
    Score: 0.023
  32. Schold JD, Srinivas TR, Braun WE, Shoskes DA, Nurko S, Poggio ED. The relative risk of overall graft loss and acute rejection among African American renal transplant recipients is attenuated with advancing age. Clin Transplant. 2011 Sep-Oct; 25(5):721-30.
    View in: PubMed
    Score: 0.023
  33. Schold JD, Srinivas TR, Poggio ED, Stephany BR, Flechner SM, Goldfarb DA, Kattan MW. Hidden selection bias deriving from donor organ characteristics does not affect performance evaluations of kidney transplant centers. Med Care. 2010 Oct; 48(10):907-14.
    View in: PubMed
    Score: 0.023
  34. Meier-Kriesche HU, Scornik JC, Susskind B, Rehman S, Schold JD. A lifetime versus a graft life approach redefines the importance of HLA matching in kidney transplant patients. Transplantation. 2009 Jul 15; 88(1):23-9.
    View in: PubMed
    Score: 0.021
  35. Schold J, Srinivas TR, Sehgal AR, Meier-Kriesche HU. Half of kidney transplant candidates who are older than 60 years now placed on the waiting list will die before receiving a deceased-donor transplant. Clin J Am Soc Nephrol. 2009 Jul; 4(7):1239-45.
    View in: PubMed
    Score: 0.021
  36. Schold JD, Harman JS, Chumbler NR, Duncan RP, Meier-Kriesche HU. The pivotal impact of center characteristics on survival of candidates listed for deceased donor kidney transplantation. Med Care. 2009 Feb; 47(2):146-53.
    View in: PubMed
    Score: 0.020
  37. Schold JD, Srinivas TR, Kayler LK, Meier-Kriesche HU. The overlapping risk profile between dialysis patients listed and not listed for renal transplantation. Am J Transplant. 2008 Jan; 8(1):58-68.
    View in: PubMed
    Score: 0.019
  38. Schold JD, Srinivas TR, Guerra G, Reed AI, Johnson RJ, Weiner ID, Oberbauer R, Harman JS, Hemming AW, Meier-Kriesche HU. A "weight-listing" paradox for candidates of renal transplantation? Am J Transplant. 2007 Mar; 7(3):550-9.
    View in: PubMed
    Score: 0.018
  39. Schold JD, Howard RJ, Scicchitano MJ, Meier-Kriesche HU. The expanded criteria donor policy: an evaluation of program objectives and indirect ramifications. Am J Transplant. 2006 Jul; 6(7):1689-95.
    View in: PubMed
    Score: 0.017
  40. Schold JD, Meier-Kriesche HU. Which renal transplant candidates should accept marginal kidneys in exchange for a shorter waiting time on dialysis? Clin J Am Soc Nephrol. 2006 May; 1(3):532-8.
    View in: PubMed
    Score: 0.017
  41. Schold JD, Kaplan B, Chumbler NR, Howard RJ, Srinivas TR, Ma L, Meier-Kriesche HU. Access to quality: evaluation of the allocation of deceased donor kidneys for transplantation. J Am Soc Nephrol. 2005 Oct; 16(10):3121-7.
    View in: PubMed
    Score: 0.016
  42. Schold JD, Kaplan B, Baliga RS, Meier-Kriesche HU. The broad spectrum of quality in deceased donor kidneys. Am J Transplant. 2005 Apr; 5(4 Pt 1):757-65.
    View in: PubMed
    Score: 0.016
  43. Bruckman D, Lee I, Schold JD, Claytor BR, Silvestri NJ, Hehir MK, Li Y. Epidemiologic Study of Myasthenia Gravis in the Elderly US Population: A Longitudinal Analysis of the Medicare Claims Database, 2006-2019. Neurology. 2024 Nov 26; 103(10):e210005.
    View in: PubMed
    Score: 0.015
  44. Abidi MZ, Lopez R, Arrigain S, Weinberg A, Kaplan B, McAdams-DeMarco M, Schold JD, Erlandson KM. Area-Level Social Deprivation and Cytomegalovirus Seropositivity at the Time of Solid Organ Transplant. JAMA Netw Open. 2024 Oct 01; 7(10):e2437878.
    View in: PubMed
    Score: 0.015
  45. Rodrigue JR, Schold JD, Glazier A, Mone TD, Hasz RD, Dils D, Grandas J, Orlowski J, Gill S, Prinz J. Racial Equity in Family Approach for Patients Medically Suitable for Deceased Organ Donation. Crit Care Med. 2024 Dec 01; 52(12):1877-1884.
    View in: PubMed
    Score: 0.015
  46. Mupfudze TG, Martinez A, Noreen SM, Stewart DE, Schold JD, Cartwright L. Individual-level social determinants of health and disparities in access to kidney transplant and waitlist mortality. PLoS One. 2024; 19(8):e0308407.
    View in: PubMed
    Score: 0.015
  47. Husain SA, Khanna S, Yu M, Adler JT, Cron DC, King KL, Schold JD, Mohan S. Cold Ischemia Time and Delayed Graft Function in Kidney Transplantation: A Paired Kidney Analysis. Transplantation. 2024 09 01; 108(9):e245-e253.
    View in: PubMed
    Score: 0.015
  48. Bakhtiyar SS, Maksimuk TE, Gutowski J, Park SY, Cain MT, Rove JY, Reece TB, Cleveland JC, Pomposelli JJ, Bababekov YJ, Nydam TL, Schold JD, Pomfret EA, Hoffman JRH. Association of procurement technique with organ yield and cost following donation after circulatory death. Am J Transplant. 2024 Oct; 24(10):1803-1815.
    View in: PubMed
    Score: 0.015
  49. King KL, Yu M, Huml AM, Schold JD, Husain SA, Mohan S. Allocation and Utilization Patterns of Deceased Donor Kidneys for Preemptive Transplantation in the United States. J Am Soc Nephrol. 2024 May 01; 35(5):642-645.
    View in: PubMed
    Score: 0.014
  50. Amdani S, Lopez R, Schold JD, Tang WHW. 30- and 60-Day Readmission Rates for Children With Heart?Failure in the United?States. JACC Heart Fail. 2024 01; 12(1):83-96.
    View in: PubMed
    Score: 0.014
  51. Tsapepas DS, King K, Husain SA, Yu ME, Hippen BE, Schold JD, Mohan S. UNOS Decisions Impact Data Integrity of the OPTN Data Registry. Transplantation. 2023 12 01; 107(12):e348-e354.
    View in: PubMed
    Score: 0.014
  52. Lee I, Schold JD, Hehir MK, Claytor B, Silvestri N, Li Y. Re: Diagnosing myasthenia gravis in older patients: Comments and observations. Muscle Nerve. 2022 10; 66(4):E24-E25.
    View in: PubMed
    Score: 0.013
  53. Lee I, Schold JD, Hehir MK, Claytor B, Silvestri N, Li Y. Validation of myasthenia gravis diagnosis in the older Medicare population. Muscle Nerve. 2022 06; 65(6):676-682.
    View in: PubMed
    Score: 0.013
  54. King KL, Husain SA, Schold JD, Patzer RE, Reese PP, Jin Z, Ratner LE, Cohen DJ, Pastan SO, Mohan S. Major Variation across Local Transplant Centers in Probability of Kidney Transplant for Wait-Listed Patients. J Am Soc Nephrol. 2020 12; 31(12):2900-2911.
    View in: PubMed
    Score: 0.012
  55. Man S, Tang AS, Schold JD, Kolikonda MK, Uchino K. The Patterns and Outcomes of Inter-Hospital Transfer Among Medicare Patients with Ischemic Stroke. J Stroke Cerebrovasc Dis. 2020 Dec; 29(12):105331.
    View in: PubMed
    Score: 0.011
  56. Klein EA, Li J, Milinovich A, Schold JD, Sharifi N, Kattan MW, Jehi L. Androgen Deprivation Therapy in Men with Prostate Cancer Does Not Affect Risk of Infection with SARS-CoV-2. J Urol. 2021 02; 205(2):441-443.
    View in: PubMed
    Score: 0.011
  57. Azem R, Daou R, Bassil E, Anvari EM, Taliercio JJ, Arrigain S, Schold JD, Vachharajani T, Nally J, Na Khoul GN. Serum magnesium, mortality and disease progression in chronic kidney disease. BMC Nephrol. 2020 02 12; 21(1):49.
    View in: PubMed
    Score: 0.011
  58. Khanna A, Fedrigon D, Monga M, Gao T, Schold J, Abouassaly R. Postoperative Emergency Department Visits After Urinary Stone Surgery: Variation Based on Surgical Modality. J Endourol. 2020 01; 34(1):93-98.
    View in: PubMed
    Score: 0.011
  59. Man S, Schold JD, Uchino K. Case Fatality Decline from 2009 to 2013 among Medicare Beneficiaries with Ischemic Stroke. J Stroke Cerebrovasc Dis. 2020 Feb; 29(2):104559.
    View in: PubMed
    Score: 0.011
  60. Lehr CJ, Lopez R, Arrigain S, Schold J, Koval C, Valapour M. The impact of change in definition of increased-risk donors on survival after lung transplant. J Thorac Cardiovasc Surg. 2020 Aug; 160(2):572-581.
    View in: PubMed
    Score: 0.011
  61. Patel KK, Shah SY, Arrigain S, Jolly S, Schold JD, Navaneethan SD, Griffin BP, Nally JV, Desai MY. Characteristics and Outcomes of Patients With Aortic Stenosis and Chronic Kidney Disease. J Am Heart Assoc. 2019 02 05; 8(3):e009980.
    View in: PubMed
    Score: 0.010
  62. Saeed F, Arrigain S, Schold JD, Nally JV, Navaneethan SD. What are the Risk Factors for One-Year Mortality in Older Patients with Chronic Kidney Disease? An Analysis of the Cleveland Clinic CKD Registry. Nephron. 2019; 141(2):98-104.
    View in: PubMed
    Score: 0.010
  63. Johnson RJ, Perez-Pozo SE, Lillo JL, Grases F, Schold JD, Kuwabara M, Sato Y, Hernando AA, Garcia G, Jensen T, Rivard C, Sanchez-Lozada LG, Roncal C, Lanaspa MA. Fructose increases risk for kidney stones: potential role in metabolic syndrome and heat stress. BMC Nephrol. 2018 11 08; 19(1):315.
    View in: PubMed
    Score: 0.010
  64. Chaudhury P, Armanyous S, Harb SC, Ferreira Provenzano L, Ashour T, Jolly SE, Arrigain S, Konig V, Schold JD, Navaneethan SD, Nally JV, Nakhoul GN. Intra-Arterial versus Intravenous Contrast and Renal Injury in Chronic Kidney Disease: A Propensity-Matched Analysis. Nephron. 2019; 141(1):31-40.
    View in: PubMed
    Score: 0.010
  65. Husain SA, Brennan C, Michelson A, Tsapepas D, Patzer RE, Schold JD, Mohan S. Patients prioritize waitlist over posttransplant outcomes when evaluating kidney transplant centers. Am J Transplant. 2018 11; 18(11):2781-2790.
    View in: PubMed
    Score: 0.010
  66. Airy M, Schold JD, Jolly SE, Arrigain S, Bansal N, Winkelmayer WC, Nally JV, Navaneethan SD. Cause-Specific Mortality in Patients with Chronic Kidney Disease and Atrial Fibrillation. Am J Nephrol. 2018; 48(1):36-45.
    View in: PubMed
    Score: 0.010
  67. Navaneethan SD, Schold JD, Walther CP, Arrigain S, Jolly SE, Virani SS, Winkelmayer WC, Nally JV. High-density lipoprotein cholesterol and causes of death in chronic kidney disease. J Clin Lipidol. 2018 Jul - Aug; 12(4):1061-1071.e7.
    View in: PubMed
    Score: 0.010
  68. Hong S, Rybicki LA, Corrigan D, Schold JD, Majhail NS. Community Risk Score for Evaluating Health Care Disparities in Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2018 04; 24(4):877-879.
    View in: PubMed
    Score: 0.009
  69. Rincon-Choles H, Jolly SE, Arrigain S, Konig V, Schold JD, Nakhoul G, Navaneethan SD, Nally JV, Rothberg MB. Impact of Uric Acid Levels on Kidney Disease Progression. Am J Nephrol. 2017; 46(4):315-322.
    View in: PubMed
    Score: 0.009
  70. Navaneethan SD, Jolly SE, Schold JD, Arrigain S, Nakhoul G, Konig V, Hyland J, Burrucker YK, Dann PD, Tucky BH, Sharp J, Nally JV. Pragmatic Randomized, Controlled Trial of Patient Navigators and Enhanced Personal Health Records in CKD. Clin J Am Soc Nephrol. 2017 Sep 07; 12(9):1418-1427.
    View in: PubMed
    Score: 0.009
  71. Man S, Schold JD, Uchino K. Impact of Stroke Center Certification on Mortality After Ischemic Stroke: The Medicare Cohort From 2009 to 2013. Stroke. 2017 09; 48(9):2527-2533.
    View in: PubMed
    Score: 0.009
  72. Navaneethan SD, Schold JD, Jolly SE, Arrigain S, Blum MF, Winkelmayer WC, Nally JV. Blood pressure parameters are associated with all-cause and cause-specific mortality in chronic kidney disease. Kidney Int. 2017 11; 92(5):1272-1281.
    View in: PubMed
    Score: 0.009
  73. Huang H, Jolly SE, Airy M, Arrigain S, Schold JD, Nally JV, Navaneethan SD. Associations of dysnatremias with mortality in chronic kidney disease. Nephrol Dial Transplant. 2017 Jul 01; 32(7):1204-1210.
    View in: PubMed
    Score: 0.009
  74. Koyawala N, Silber JH, Rosenbaum PR, Wang W, Hill AS, Reiter JG, Niknam BA, Even-Shoshan O, Bloom RD, Sawinski D, Nazarian S, Trofe-Clark J, Lim MA, Schold JD, Reese PP. Comparing Outcomes between Antibody Induction Therapies in Kidney Transplantation. J Am Soc Nephrol. 2017 Jul; 28(7):2188-2200.
    View in: PubMed
    Score: 0.009
  75. Navaneethan SD, Schold JD, Jolly SE, Arrigain S, Winkelmayer WC, Nally JV. Diabetes Control and the Risks of ESRD and Mortality in?Patients?With CKD. Am J Kidney Dis. 2017 Aug; 70(2):191-198.
    View in: PubMed
    Score: 0.009
  76. Sakhuja A, Wright RS, Schold JD, McCarthy JT, Williams AW, Amer H, Albright RC. National Impact of Maintenance Dialysis or Renal Transplantation on Outcomes Following ST Elevation Myocardial Infarction. Am J Nephrol. 2016; 44(5):329-338.
    View in: PubMed
    Score: 0.009
  77. Dalton JE, Zidar DA, Udeh BL, Patel MR, Schold JD, Dawson NV. Practice Variation Among Hospitals in Revascularization Therapy and Its Association With Procedure-related Mortality. Med Care. 2016 06; 54(6):623-31.
    View in: PubMed
    Score: 0.009
  78. Bagga HS, Lin S, Williams A, Schold J, Chertack N, Goldfarb D, Wood H. Trends in Renal Transplantation Rates in Patients with Congenital Urinary Tract Disorders. J Urol. 2016 Apr; 195(4 Pt 2):1257-62.
    View in: PubMed
    Score: 0.008
  79. Navaneethan SD, Schold JD, Huang H, Nakhoul G, Jolly SE, Arrigain S, Dweik RA, Nally JV. Mortality Outcomes of Patients with Chronic Kidney Disease and Chronic Obstructive Pulmonary Disease. Am J Nephrol. 2016; 43(1):39-46.
    View in: PubMed
    Score: 0.008
  80. Sakhuja A, Naik A, Amer H, Cibrik D, Eikstadt R, Schold JD, Stegall MD. Underutilization of Timely Kidney Transplants in Those With Living Donors. Am J Transplant. 2016 Mar; 16(3):1007-14.
    View in: PubMed
    Score: 0.008
  81. Navaneethan SD, Schold JD, Arrigain S, Kirwan JP, Nally JV. Body mass index and causes of death in chronic kidney disease. Kidney Int. 2016 Mar; 89(3):675-82.
    View in: PubMed
    Score: 0.008
  82. Nakhoul GN, Huang H, Arrigain S, Jolly SE, Schold JD, Nally JV, Navaneethan SD. Serum Potassium, End-Stage Renal Disease and Mortality in Chronic Kidney Disease. Am J Nephrol. 2015; 41(6):456-63.
    View in: PubMed
    Score: 0.008
  83. Nakhoul GN, Schold JD, Arrigain S, Harb SC, Jolly S, Wilkoff BL, Nally JV, Navaneethan SD. Implantable cardioverter-defibrillators in patients with CKD: a propensity-matched mortality analysis. Clin J Am Soc Nephrol. 2015 Jul 07; 10(7):1119-27.
    View in: PubMed
    Score: 0.008
  84. Toledo C, Thomas G, Schold JD, Arrigain S, Gornik HL, Nally JV, Navaneethan SD. Renal resistive index and mortality in chronic kidney disease. Hypertension. 2015 Aug; 66(2):382-8.
    View in: PubMed
    Score: 0.008
  85. Navaneethan SD, Schold JD, Arrigain S, Jolly SE, Nally JV. Cause-Specific Deaths in Non-Dialysis-Dependent CKD. J Am Soc Nephrol. 2015 Oct; 26(10):2512-20.
    View in: PubMed
    Score: 0.008
  86. Rodrigue JR, Schold JD, Morrissey P, Whiting J, Vella J, Kayler LK, Katz D, Jones J, Kaplan B, Fleishman A, Pavlakis M, Mandelbrot DA. Predonation Direct and Indirect Costs Incurred by Adults Who Donated a Kidney: Findings From the KDOC Study. Am J Transplant. 2015 Sep; 15(9):2387-93.
    View in: PubMed
    Score: 0.008
  87. Saeed F, Adil MM, Malik AA, Schold JD, Holley JL. Outcomes of In-Hospital Cardiopulmonary Resuscitation in Maintenance Dialysis Patients. J Am Soc Nephrol. 2015 Dec; 26(12):3093-101.
    View in: PubMed
    Score: 0.008
  88. Prakash S, McGrail A, Lewis SA, Schold J, Lawless ME, Sehgal AR, Perzynski AT. Behavioral stage of change and dialysis decision-making. Clin J Am Soc Nephrol. 2015 Feb 06; 10(2):197-204.
    View in: PubMed
    Score: 0.008
  89. Rodrigue JR, Paek MJ, Egbuna O, Waterman AD, Schold JD, Pavlakis M, Mandelbrot DA. Readiness of wait-listed black patients to pursue live donor kidney transplant. Prog Transplant. 2014 Dec; 24(4):355-61.
    View in: PubMed
    Score: 0.008
  90. Opelami O, Sakhuja A, Liu X, Tang WH, Schold JD, Navaneethan SD. Outcomes of infected cardiovascular implantable devices in dialysis patients. Am J Nephrol. 2014; 40(3):280-7.
    View in: PubMed
    Score: 0.008
  91. Navaneethan SD, Sakhuja A, Arrigain S, Sharp J, Schold JD, Nally JV. Practice patterns of phosphate binder use and their associations with mortality in chronic kidney disease. Clin Nephrol. 2014 Jul; 82(1):16-25.
    View in: PubMed
    Score: 0.007
  92. Khurana KK, Navaneethan SD, Arrigain S, Schold JD, Nally JV, Shoskes DA. Serum testosterone levels and mortality in men with CKD stages 3-4. Am J Kidney Dis. 2014 Sep; 64(3):367-74.
    View in: PubMed
    Score: 0.007
  93. Braun WE, Schold JD, Stephany BR, Spirko RA, Herts BR. Low-dose rapamycin (sirolimus) effects in autosomal dominant polycystic kidney disease: an open-label randomized controlled pilot study. Clin J Am Soc Nephrol. 2014 May; 9(5):881-8.
    View in: PubMed
    Score: 0.007
  94. Jolly SE, Navaneethan SD, Schold JD, Arrigain S, Sharp JW, Jain AK, Schreiber MJ, Simon JF, Nally JV. Chronic kidney disease in an electronic health record problem list: quality of care, ESRD, and mortality. Am J Nephrol. 2014; 39(4):288-96.
    View in: PubMed
    Score: 0.007
  95. Navaneethan SD, Wehbe E, Heresi GA, Gaur V, Minai OA, Arrigain S, Nally JV, Schold JD, Rahman M, Dweik RA. Presence and outcomes of kidney disease in patients with pulmonary hypertension. Clin J Am Soc Nephrol. 2014 May; 9(5):855-63.
    View in: PubMed
    Score: 0.007
  96. Crews DC, Scialla JJ, Boulware LE, Navaneethan SD, Nally JV, Liu X, Arrigain S, Schold JD, Ephraim PL, Jolly SE, Sozio SM, Michels WM, Miskulin DC, Tangri N, Shafi T, Wu AW, Bandeen-Roche K. Comparative effectiveness of early versus conventional timing of dialysis initiation in advanced CKD. Am J Kidney Dis. 2014 May; 63(5):806-15.
    View in: PubMed
    Score: 0.007
  97. van Duin D, Avery RK, Hemachandra S, Yen-Lieberman B, Zhang A, Jain A, Butler RS, Barnard J, Schold JD, Fung J, Askar M. KIR and HLA interactions are associated with control of primary CMV infection in solid organ transplant recipients. Am J Transplant. 2014 Jan; 14(1):156-62.
    View in: PubMed
    Score: 0.007
  98. Elfadawy N, Flechner SM, Liu X, Schold J, Srinivas TR, Poggio E, Fatica R, Avery R, Mossad SB. CMV Viremia is associated with a decreased incidence of BKV reactivation after kidney and kidney-pancreas transplantation. Transplantation. 2013 Dec 27; 96(12):1097-103.
    View in: PubMed
    Score: 0.007
  99. Sakhuja A, Schold JD, Kumar G, Katzan I, Navaneethan SD. Nontraumatic subarachnoid hemorrhage in maintenance dialysis hospitalizations: trends and outcomes. Stroke. 2014 Jan; 45(1):71-6.
    View in: PubMed
    Score: 0.007
  100. Elfadawy N, Flechner SM, Liu X, Schold J, Tian D, Srinivas TR, Poggio E, Fatica R, Avery R, Mossad SB. The impact of surveillance and rapid reduction in immunosuppression to control BK virus-related graft injury in kidney transplantation. Transpl Int. 2013 Aug; 26(8):822-32.
    View in: PubMed
    Score: 0.007
  101. Taliercio JJ, Schold JD, Simon JF, Arrigain S, Tang A, Saab G, Nally JV, Navaneethan SD. Prognostic importance of serum alkaline phosphatase in CKD stages 3-4 in a clinical population. Am J Kidney Dis. 2013 Oct; 62(4):703-10.
    View in: PubMed
    Score: 0.007
  102. Sakhuja A, Schold JD, Kumar G, Dall A, Sood P, Navaneethan SD. Outcomes of patients receiving maintenance dialysis admitted over weekends. Am J Kidney Dis. 2013 Oct; 62(4):763-70.
    View in: PubMed
    Score: 0.007
  103. Navaneethan SD, Schold JD, Kirwan JP, Arrigain S, Jolly SE, Poggio ED, Beddhu S, Nally JV. Metabolic syndrome, ESRD, and death in CKD. Clin J Am Soc Nephrol. 2013 Jun; 8(6):945-52.
    View in: PubMed
    Score: 0.007
  104. Navaneethan SD, Schold JD, Arrigain S, Thomas G, Jolly SE, Poggio ED, Schreiber MJ, Sarnak MJ, Nally JV. Serum triglycerides and risk for death in Stage 3 and Stage 4 chronic kidney disease. Nephrol Dial Transplant. 2012 Aug; 27(8):3228-34.
    View in: PubMed
    Score: 0.006
  105. Demirjian S, Schold JD, Navia J, Mastracci TM, Paganini EP, Yared JP, Bashour CA. Predictive models for acute kidney injury following cardiac surgery. Am J Kidney Dis. 2012 Mar; 59(3):382-9.
    View in: PubMed
    Score: 0.006
  106. Navaneethan SD, Schold JD, Arrigain S, Jolly SE, Wehbe E, Raina R, Simon JF, Srinivas TR, Jain A, Schreiber MJ, Nally JV. Serum bicarbonate and mortality in stage 3 and stage 4 chronic kidney disease. Clin J Am Soc Nephrol. 2011 Oct; 6(10):2395-402.
    View in: PubMed
    Score: 0.006
  107. Navaneethan SD, Schold JD, Arrigain S, Jolly SE, Jain A, Schreiber MJ, Simon JF, Srinivas TR, Nally JV. Low 25-hydroxyvitamin D levels and mortality in non-dialysis-dependent CKD. Am J Kidney Dis. 2011 Oct; 58(4):536-43.
    View in: PubMed
    Score: 0.006
  108. Askar M, Schold JD, Eghtesad B, Flechner SM, Kaplan B, Klingman L, Zein NN, Fung J, Srinivas TR. Combined liver-kidney transplants: allosensitization and recipient outcomes. Transplantation. 2011 Jun 15; 91(11):1286-92.
    View in: PubMed
    Score: 0.006
  109. Navaneethan SD, Jolly SE, Schold JD, Arrigain S, Saupe W, Sharp J, Lyons J, Simon JF, Schreiber MJ, Jain A, Nally JV. Development and validation of an electronic health record-based chronic kidney disease registry. Clin J Am Soc Nephrol. 2011 Jan; 6(1):40-9.
    View in: PubMed
    Score: 0.006
  110. Bihorac A, Delano MJ, Schold JD, Lopez MC, Nathens AB, Maier RV, Layon AJ, Baker HV, Moldawer LL. Incidence, clinical predictors, genomics, and outcome of acute kidney injury among trauma patients. Ann Surg. 2010 Jul; 252(1):158-65.
    View in: PubMed
    Score: 0.006
  111. Perez-Pozo SE, Schold J, Nakagawa T, S?nchez-Lozada LG, Johnson RJ, Lillo JL. Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response. Int J Obes (Lond). 2010 Mar; 34(3):454-61.
    View in: PubMed
    Score: 0.005
  112. Ejaz AA, Beaver TM, Shimada M, Sood P, Lingegowda V, Schold JD, Kim T, Johnson RJ. Uric acid: a novel risk factor for acute kidney injury in high-risk cardiac surgery patients? Am J Nephrol. 2009; 30(5):425-9.
    View in: PubMed
    Score: 0.005
  113. Meier-Kriesche HU, Schold JD, Vanrenterghem Y, Halloran PF, Ekberg H. Uric acid levels have no significant effect on renal function in adult renal transplant recipients: evidence from the symphony study. Clin J Am Soc Nephrol. 2009 Oct; 4(10):1655-60.
    View in: PubMed
    Score: 0.005
  114. Cable C, Buzzeo MP, Schold JD, Khan S, Leather H, Moreb J, Jamieson K, Scornik J, Amdur RJ, Wingard JR, Reddy V. Reduced-intensity conditioning using fludarabine with either antithymocyte globulin and BU, or low-dose TBI allowing allogeneic hematopoietic SCT. Bone Marrow Transplant. 2010 Jan; 45(1):31-7.
    View in: PubMed
    Score: 0.005
  115. Bihorac A, Yavas S, Subbiah S, Hobson CE, Schold JD, Gabrielli A, Layon AJ, Segal MS. Long-term risk of mortality and acute kidney injury during hospitalization after major surgery. Ann Surg. 2009 May; 249(5):851-8.
    View in: PubMed
    Score: 0.005
  116. Hobson CE, Yavas S, Segal MS, Schold JD, Tribble CG, Layon AJ, Bihorac A. Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation. 2009 May 12; 119(18):2444-53.
    View in: PubMed
    Score: 0.005
  117. Srinivas TR, Schold JD, Guerra G, Eagan A, Bucci CM, Meier-Kriesche HU. Mycophenolate mofetil/sirolimus compared to other common immunosuppressive regimens in kidney transplantation. Am J Transplant. 2007 Mar; 7(3):586-94.
    View in: PubMed
    Score: 0.004
  118. Lansang MC, Ma L, Schold JD, Meier-Kriesche HU, Kaplan B. The relationship between diabetes and infectious hospitalizations in renal transplant recipients. Diabetes Care. 2006 Jul; 29(7):1659-60.
    View in: PubMed
    Score: 0.004
  119. Howard RJ, Schold JD, Cornell DL. A 10-year analysis of organ donation after cardiac death in the United States. Transplantation. 2005 Sep 15; 80(5):564-8.
    View in: PubMed
    Score: 0.004
  120. Meier-Kriesche HU, Schold JD, Srinivas TR, Howard RJ, Fujita S, Kaplan B. Sirolimus in combination with tacrolimus is associated with worse renal allograft survival compared to mycophenolate mofetil combined with tacrolimus. Am J Transplant. 2005 Sep; 5(9):2273-80.
    View in: PubMed
    Score: 0.004
  121. Meier-Kriesche HU, Schold JD, Gaston RS, Wadstrom J, Kaplan B. Kidneys from deceased donors: maximizing the value of a scarce resource. Am J Transplant. 2005 Jul; 5(7):1725-30.
    View in: PubMed
    Score: 0.004
  122. Koc M, Richards HB, Bihorac A, Ross EA, Schold JD, Segal MS. Circulating endothelial cells are associated with future vascular events in hemodialysis patients. Kidney Int. 2005 Mar; 67(3):1078-83.
    View in: PubMed
    Score: 0.004
  123. Meier-Kriesche HU, Schold JD, Srinivas TR, Reed A, Kaplan B. Kidney transplantation halts cardiovascular disease progression in patients with end-stage renal disease. Am J Transplant. 2004 Oct; 4(10):1662-8.
    View in: PubMed
    Score: 0.004
  124. Meier-Kriesche HU, Schold JD, Kaplan B. Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am J Transplant. 2004 Aug; 4(8):1289-95.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)